On the 28th day post-injection of cancer cells, the tumor growth, monitored by bioluminescence, was significantly promoted in CGN-mutant tumors compared to WT, and it cannot be suppressed by oxaliplatin treatment (Fig. 2B and C; Supplementary Fig. S5A and B). This evidence concerns the gene CGN and neoplasm.